SI2928881T1 - New pyridine derivatives - Google Patents

New pyridine derivatives Download PDF

Info

Publication number
SI2928881T1
SI2928881T1 SI201331023T SI201331023T SI2928881T1 SI 2928881 T1 SI2928881 T1 SI 2928881T1 SI 201331023 T SI201331023 T SI 201331023T SI 201331023 T SI201331023 T SI 201331023T SI 2928881 T1 SI2928881 T1 SI 2928881T1
Authority
SI
Slovenia
Prior art keywords
pyridine
cyclopropylmethoxy
amide
carboxylic acid
carbamoylmethyl
Prior art date
Application number
SI201331023T
Other languages
English (en)
Slovenian (sl)
Inventor
Beat Frei
Luca Gobbi
Uwe Grether
Atsushi Kimbara
Matthias Nettekoven
Stephan Roever
Mark Rogers-Evans
Tanja Schulz-Gasch
Original Assignee
F.Hoffmann-La RocheAG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La RocheAG filed Critical F.Hoffmann-La RocheAG
Publication of SI2928881T1 publication Critical patent/SI2928881T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SI201331023T 2012-12-07 2013-12-02 New pyridine derivatives SI2928881T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12196022 2012-12-07
EP13799520.5A EP2928881B1 (en) 2012-12-07 2013-12-02 Novel pyridine derivatives
PCT/EP2013/075225 WO2014086705A1 (en) 2012-12-07 2013-12-02 Novel pyridine derivatives

Publications (1)

Publication Number Publication Date
SI2928881T1 true SI2928881T1 (en) 2018-07-31

Family

ID=47290804

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201331023T SI2928881T1 (en) 2012-12-07 2013-12-02 New pyridine derivatives

Country Status (33)

Country Link
US (1) US9522886B2 (https=)
EP (2) EP3357918A1 (https=)
JP (1) JP6426618B2 (https=)
KR (1) KR20150092282A (https=)
CN (2) CN104837831B (https=)
AR (1) AR093843A1 (https=)
AU (2) AU2013354278B2 (https=)
BR (1) BR112015012919A2 (https=)
CA (1) CA2890100A1 (https=)
CL (1) CL2015001536A1 (https=)
CO (1) CO7350620A2 (https=)
CR (1) CR20150250A (https=)
DK (1) DK2928881T3 (https=)
EA (1) EA026669B1 (https=)
ES (1) ES2668690T3 (https=)
HR (1) HRP20180672T1 (https=)
HU (1) HUE036911T2 (https=)
IL (1) IL239075B (https=)
LT (1) LT2928881T (https=)
MA (1) MA38239A1 (https=)
MX (1) MX2015007155A (https=)
NO (1) NO2928881T3 (https=)
PE (1) PE20151025A1 (https=)
PH (1) PH12015501083B1 (https=)
PL (1) PL2928881T3 (https=)
PT (1) PT2928881T (https=)
RS (1) RS57143B1 (https=)
SG (2) SG10201800170YA (https=)
SI (1) SI2928881T1 (https=)
TW (1) TWI600645B (https=)
UA (1) UA114656C2 (https=)
WO (1) WO2014086705A1 (https=)
ZA (1) ZA201503969B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014224784B2 (en) 2013-03-07 2018-03-08 F. Hoffmann-La Roche Ag Novel pyrazol derivatives
CN105121436B (zh) 2013-03-26 2018-07-27 豪夫迈·罗氏有限公司 新的吡啶衍生物
AU2014261585B2 (en) 2013-05-02 2018-03-08 F. Hoffmann-La Roche Ag Purine derivatives as CB2 receptor agonists
WO2014177527A1 (en) 2013-05-02 2014-11-06 F. Hoffmann-La Roche Ag Pyrrolo[2,3-d]pyrimidine derivatives as cb2 receptor agonists
JP6441356B2 (ja) 2013-09-06 2018-12-19 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 新規トリアゾロ［４，５−ｄ］ピリミジン誘導体
CN111170938A (zh) * 2014-04-04 2020-05-19 豪夫迈·罗氏有限公司 作为大麻素受体激动剂的5,6-双取代的吡啶-2-甲酰胺
WO2015190564A1 (ja) * 2014-06-13 2015-12-17 武田薬品工業株式会社 含窒素複素環化合物
EP3386951B1 (en) * 2015-12-09 2020-02-26 H. Hoffnabb-La Roche Ag Phenyl derivatives as cannabinoid receptor 2 agonists
WO2017107089A1 (en) 2015-12-23 2017-06-29 Merck Sharp & Dohme Corp. 3- (1h-pyrazol-4-yl) pyridineallosteric modulators of the m4 muscarinic acetylcholine receptor
AR112199A1 (es) 2017-06-20 2019-10-02 Hoffmann La Roche Derivados de piridina como agonistas inversos del receptor cannabinoide 2
JP2021521228A (ja) * 2018-04-18 2021-08-26 ビーエイエスエフ・ソシエタス・エウロパエアＢａｓｆ Ｓｅ Ｄ−グルカロ−６，３−ラクトンモノエステル及びその製造方法
JP7456948B2 (ja) 2018-06-27 2024-03-27 エフ． ホフマン－ラ ロシュ アーゲー 放射性標識カンナビノイド受容体２リガンド
EP3814337B1 (en) * 2018-06-27 2025-05-14 F. Hoffmann-La Roche AG Pyridine and pyrazine derivatives as preferential cannabinoid 2 agonists
CN112119068A (zh) * 2018-06-27 2020-12-22 豪夫迈·罗氏有限公司 作为大麻素受体2的抑制剂的新型氮杂环丁烷-取代的吡啶和吡嗪化合物
PE20210368A1 (es) 2018-06-27 2021-02-26 Eth Zuerich Nuevos compuestos de piridina y pirazina como inhibidores del receptor cannabinoide 2
CN114502538A (zh) * 2019-09-30 2022-05-13 豪夫迈·罗氏有限公司 用于治疗和预防乙型肝炎病毒感染的经取代的3,4-二氢喹唑啉
JP2023541601A (ja) 2020-09-10 2023-10-03 プレシリックス・ナームローゼ・ベンノートシヤープ Ｆａｐに対する抗体フラグメント
MX2023012365A (es) * 2021-04-19 2023-11-27 Chemocentryx Inc Azetidinil-acetamidas como inhibidores de cxcr7.
WO2023203135A1 (en) 2022-04-22 2023-10-26 Precirix N.V. Improved radiolabelled antibody
CA3251753A1 (en) 2022-05-02 2023-11-09 Precirix N.V. PRE-TARGETTING

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008040649A2 (en) * 2006-10-04 2008-04-10 F. Hoffmann-La Roche Ag Pyrazine-2-carboxamide derivatives as cb2 receptor modulators
WO2012031817A1 (en) * 2010-09-09 2012-03-15 F. Hoffmann-La Roche Ag Determination of abca1 protein levels in cells
AR085013A1 (es) * 2011-01-26 2013-08-07 Sanofi Aventis Derivados de acido 3-heteroaroilamino-propionico sustituidos y su uso como sustancias farmaceuticas
US9321727B2 (en) * 2011-06-10 2016-04-26 Hoffmann-La Roche Inc. Pyridine derivatives as agonists of the CB2 receptor

Also Published As

Publication number Publication date
HK1208031A1 (en) 2016-02-19
JP6426618B2 (ja) 2018-11-21
IL239075A0 (en) 2015-07-30
EP3357918A1 (en) 2018-08-08
AU2017279648A1 (en) 2018-01-18
CL2015001536A1 (es) 2015-10-23
KR20150092282A (ko) 2015-08-12
DK2928881T3 (en) 2018-05-28
HUE036911T2 (hu) 2018-08-28
EP2928881A1 (en) 2015-10-14
WO2014086705A1 (en) 2014-06-12
CN104837831A (zh) 2015-08-12
IL239075B (en) 2018-11-29
HRP20180672T1 (hr) 2018-06-01
SG11201504416XA (en) 2015-07-30
SG10201800170YA (en) 2018-02-27
AU2013354278B2 (en) 2017-10-12
MX2015007155A (es) 2015-10-14
RS57143B1 (sr) 2018-07-31
CR20150250A (es) 2015-06-11
JP2016501240A (ja) 2016-01-18
AU2013354278A1 (en) 2015-05-14
CO7350620A2 (es) 2015-08-10
LT2928881T (lt) 2018-06-11
US9522886B2 (en) 2016-12-20
BR112015012919A2 (pt) 2017-07-11
PH12015501083A1 (en) 2015-08-03
NO2928881T3 (https=) 2018-08-11
UA114656C2 (uk) 2017-07-10
TWI600645B (zh) 2017-10-01
TW201427951A (zh) 2014-07-16
MA38239A1 (fr) 2017-03-31
EP2928881B1 (en) 2018-03-14
CN104837831B (zh) 2017-10-31
PE20151025A1 (es) 2015-07-15
PT2928881T (pt) 2018-05-07
EA201591064A1 (ru) 2015-09-30
CA2890100A1 (en) 2014-06-12
PL2928881T3 (pl) 2018-07-31
ZA201503969B (en) 2016-04-28
CN107674061A (zh) 2018-02-09
US20150307452A1 (en) 2015-10-29
ES2668690T3 (es) 2018-05-21
PH12015501083B1 (en) 2015-08-03
EA026669B1 (ru) 2017-05-31
AR093843A1 (es) 2015-06-24

Similar Documents

Publication Publication Date Title
SI2928881T1 (en) New pyridine derivatives
JP2016501240A5 (https=)
CN104837818B (zh) 可用作cb2激动剂的吡啶‑2‑酰胺
JP5997265B2 (ja) Ｃｂ２アゴニストとして有用なピリジン−２−アミド
JP6397410B2 (ja) 芳香環化合物
JP3922884B2 (ja) ベンゾフリルピロン誘導体
JP6500010B2 (ja) 新規ピリジン誘導体
JP2019069941A (ja) スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用
HRP20170572T1 (hr) Derivati pirazina kao agonisti receptora cb2
WO2017195216A4 (en) Cyclopropyl-amide compounds as dual lsd1/hdac inhibitors
RU2015121948A (ru) Агонист рецептора gpr40, способы его получения и фармацевтические композиции, содержащие его в качестве активного ингредиента
KR101615779B1 (ko) 면역조절제로서 피리딘-2-일 유도체
EP2842955A1 (en) Trk-INHIBITING COMPOUND
ME02297B (me) Jedinjenja koja imaju aktivnost antagonista muskarinskih receptora i agonist beta2 adrenergičnog receptora
PE20121440A1 (es) Derivados de oxazina y su uso como inhibidores de bace para el tratamiento de trastornos neurologicos
WO2014180562A1 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
JP2007532651A5 (https=)
KR20150137095A (ko) 치환된 옥소피리딘 유도체 및 심혈관 장애의 치료에서의 그의 용도
BR112012028527A2 (pt) composto de amida, composição farmacêutica e inibidor de 11â-hsd1 compreendendo o dito composto e usos do dito composto
JP2008513516A5 (https=)
HRP20161702T1 (hr) Novi derivati pirazina
JPWO1999046262A1 (ja) ベンゾフリルピロン誘導体
TW202208359A (zh) 新穎二醯基甘油酯o-醯基轉移酶2抑制劑
JP4894517B2 (ja) ２−フェニルピリジン誘導体
CN116507613A (zh) 稳定转甲状腺蛋白四聚体的视黄醇结合蛋白4的双特异性拮抗剂及其制备和在治疗常见年龄相关合并症中的用途